PRELUDE CAPITAL MANAGEMENT, LLC - RENEO PHARMACEUTICALS INC ownership

RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 59 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 1.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of RENEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$112,702
+16.1%
14,8000.0%0.01%
+16.7%
Q2 2023$97,088
+9.7%
14,8000.0%0.01%
+20.0%
Q1 2023$88,50414,8000.01%
Other shareholders
RENEO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 2,409,220$8,071,0009.37%
Abingworth LLP 2,073,957$6,948,0002.38%
Aisling Capital Management LP 886,075$2,968,0001.97%
NEA Management Company, LLC 4,786,921$16,036,0000.80%
Novo Holdings A/S 3,430,377$11,492,0000.55%
Ikarian Capital, LLC 155,819$521,0000.10%
Rock Springs Capital Management LP 1,143,185$3,830,0000.10%
Ergoteles LLC 37,640$126,0000.00%
MAI Capital Management 63,210$212,0000.00%
RBF Capital, LLC 14,536$49,0000.00%
View complete list of RENEO PHARMACEUTICALS INC shareholders